Maravai Lifesciences Holdings annual revenue
2019
2020
2021
2022
2023
2024
2025
Maravai Lifesciences Holdings Revenue Growth & History (MRVI)
Maravai Lifesciences Holdings reported $185.7M in revenue for fiscal 2025, a decrease of 28.34% from the previous fiscal year.
View full Maravai Lifesciences Holdings company overviewMaravai Lifesciences Holdings annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $185.7M | −$73.4M | −28.34% |
| 2024 | 2024-12-31 | $259.2M | −$29.8M | −10.30% |
| 2023 | 2023-12-31 | $288.9M | −$594.1M | −67.28% |
| 2022 | 2022-12-31 | $883.0M | $83.8M | +10.48% |
| 2021 | 2021-12-31 | $799.2M | $515.1M | +181.33% |
| 2020 · Dec 31 | 2020-12-31 | $284.1M | $141.0M | +98.48% |
| 2019 | 2019-12-31 | $143.1M | — | — |
Maravai Lifesciences Holdings quarterly revenue
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $51.4M | $4.0M | +8.53% |
| Q1 2026 | 2026-03-31 | $65.8M | $19.0M | +40.53% |
| Q4 2025 | 2025-12-31 | $49.9M | −$6.7M | −11.83% |
| Q3 2025 | 2025-09-30 | $41.6M | −$27.4M | −39.69% |
| Q2 2025 | 2025-06-30 | $47.4M | −$22.0M | −31.73% |
| Q1 2025 | 2025-03-31 | $46.9M | −$17.3M | −27.00% |
| Q4 2024 | 2024-12-31 | $56.6M | −$17.6M | −23.72% |
| Q3 2024 | 2024-09-30 | $69.0M | $2.2M | +3.23% |
| Q2 2024 | 2024-06-30 | $69.4M | $509,000 | +0.74% |
| Q1 2024 | 2024-03-31 | $64.2M | −$14.8M | −18.79% |
| Q4 2023 | 2023-12-31 | $74.1M | −$130.6M | −63.78% |
| Q3 2023 | 2023-09-30 | $66.9M | −$124.4M | −65.04% |
| Q2 2023 | 2023-06-30 | $68.9M | −$173.8M | −71.61% |
| Q1 2023 | 2023-03-31 | $79.0M | −$165.3M | −67.65% |
| Q4 2022 | 2022-12-31 | $204.7M | −$23.7M | −10.39% |
| Q3 2022 | 2022-09-30 | $191.3M | −$13.5M | −6.61% |
| Q2 2022 | 2022-06-30 | $242.7M | $25.0M | +11.46% |
| Q1 2022 | 2022-03-31 | $244.3M | $96.1M | +64.83% |
| Q4 2021 | 2021-12-31 | $228.4M | $130.1M | +132.27% |
| Q3 2021 | 2021-09-30 | $204.8M | $117.0M | +133.11% |
| Q2 2021 | 2021-06-30 | $217.8M | $170.9M | +364.29% |
| Q1 2021 | 2021-03-31 | $148.2M | $97.2M | +190.72% |
| Q4 2020 | 2020-12-31 | $98.4M | — | — |
| Q3 2020 | 2020-09-30 | $87.9M | — | — |
| Q2 2020 | 2020-06-30 | $46.9M | — | — |
| Q1 2020 | 2020-03-31 | $51.0M | — | — |
Maravai Lifesciences Holdings revenue growth trends
Over the last five reported fiscal years, revenue declined from $284.1M to $185.7M, a compound annual decline of 8.15%. Maravai Lifesciences Holdings's latest reported quarter, Q2 2026, generated $51.4M in revenue, an increase of 8.53% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Maravai Lifesciences Holdings source filings ↗